Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site

Autor: James J. Robinson, Alan L. Hudson, David J. Nutt, Robin J. Tyacke, Atsuko Kimura, Michael C.W. Minchin, Stephen M. Husbands
Rok vydání: 2009
Předmět:
Research Report
Male
Models
Molecular

2-BFI
2-(2-benzofuranyl)2-imidazoline

MOE
molecular operating environment

Imidazoline binding protein
2-BFI
Imidazoline receptor
BU224
2-(4
5-dihydroimidaz-2-yl)quinoline

0302 clinical medicine
GR
glucose-responsive

0303 health sciences
GOLD
genetic optimisation for ligand docking

General Neuroscience
Imidazoles
Brain
3. Good health
I2
imidazoline-2 subtype

Biochemistry
Female
Rabbits
Binding domain
MAO
monoamine oxidase

Neuroscience(all)
Clinical Neurology
Biology
DNA-binding protein
03 medical and health sciences
Affinity chromatography
Creatine Kinase
BB Form

Chemical specificity
Animals
Creatine kinase
Rats
Wistar

Binding site
BU99006
5-isothiocyanoato-2-benzofuranyl-2-imidazoline

Molecular Biology
Benzofurans
030304 developmental biology
Binding Sites
Dose-Response Relationship
Drug

Binding protein
Cell Membrane
Cooperative binding
Harmane and psychiatric disorders
Rats
Enzyme Activation
KATP channel
ATP sensitive potassium channel

B-CK
brain creatine kinase

Imidazoline Receptors
Neurology (clinical)
Chickens
CK
creatine kinase

030217 neurology & neurosurgery
Developmental Biology
Zdroj: Brain Research
ISSN: 0006-8993
DOI: 10.1016/j.brainres.2009.04.044
Popis: Drugs that bind to imidazoline binding proteins have major physiological actions. To date, three subtypes of such proteins, I(1), I(2) and I(3), have been proposed, although characterisations of these binding proteins are lacking. I(2) binding sites are found throughout the brain, particularly dense in the arcuate nucleus of the hypothalamus. Selective I(2) ligands demonstrate antidepressant-like activity and the identity of the proteins that respond to such ligands remained unknown until now. Here we report the isolation of a approximately 45 kDa imidazoline binding protein from rabbit and rat brain using a high affinity ligand for the I(2) subtype, 2-BFI, to generate an affinity column. Following protein sequencing of the isolated approximately 45 kDa imidazoline binding protein, we identified it to be brain creatine kinase (B-CK). B-CK shows high binding capacity to selective I(2) ligands; [(3)H]-2-BFI (5 nM) specifically bound to B-CK (2330+/-815 fmol mg protein(-1)). We predicted an I(2) binding pocket near the active site of B-CK using molecular modelling. Furthermore, B-CK activity was inhibited by a selective I(2) irreversible ligand, where 20 microM BU99006 reduced the enzyme activity by 16%, confirming the interaction between B-CK and the I(2) ligand. In summary, we have identified B-CK to be the approximately 45 kDa imidazoline binding protein and we have demonstrated the existence of an I(2) binding site within this enzyme. The importance of B-CK in regulating neuronal activity and neurotransmitter release may well explain the various actions of I(2) ligands in brain and the alterations in densities of I(2) binding sites in psychiatric disorders.
Databáze: OpenAIRE